S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
CVE:CZO

Ceapro Inc. (CZO.V) Stock Forecast, Price & News

C$0.68
-0.01 (-1.45 %)
(As of 01/22/2021 12:00 PM ET)
Add
Compare
Today's Range
C$0.68
Now: C$0.68
C$0.69
50-Day Range
C$0.01
MA: C$0.67
C$0.72
52-Week Range
C$0.14
Now: C$0.68
C$0.98
Volume27,300 shs
Average Volume64,084 shs
Market CapitalizationC$52.78 million
P/E Ratio20.61
Dividend YieldN/A
BetaN/A
Ceapro Inc., a biotechnology company, engages in the development and commercialization of active ingredients in the United States, Germany, China, Canada, and internationally. It operates in two segments, The Active Ingredient Product Technology Industry and The Cosmeceutical Industry. The company is involved in the development and application of technology to the production of extracts and active ingredients from oats and other renewable plant resources. It adds value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company's products include natural active ingredients comprising beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; natural anti-aging skincare products; and veterinary therapeutic products, such as oat shampoos, ear cleansers, and dermal complexes/conditioners. Its products and technologies that are under research and development, or pre-commercial stage comprise a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; various novel enabling technologies, such as Pressurized Gas eXpanded drying technology; and technologies to enhance the content of avenanthramides. The company has a collaboration with the McMaster University to develop inhalable therapeutic for COVID-19. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada.

MarketRank

Overall MarketRank

0.69 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-780-4214555
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$16.14 million
Cash FlowC$0.08 per share
Book ValueC$0.32 per share

Profitability

Miscellaneous

Market CapC$52.78 million
Next Earnings Date4/15/2021 (Estimated)
OptionableNot Optionable
C$0.68
-0.01 (-1.45 %)
(As of 01/22/2021 12:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CZO News and Ratings via Email

Sign-up to receive the latest news and ratings for CZO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ceapro Inc. (CZO.V) (CVE:CZO) Frequently Asked Questions

How has Ceapro Inc. (CZO.V)'s stock price been impacted by COVID-19?

Ceapro Inc. (CZO.V)'s stock was trading at C$0.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CZO stock has increased by 209.1% and is now trading at C$0.68.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Ceapro Inc. (CZO.V)?

Wall Street analysts have given Ceapro Inc. (CZO.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Ceapro Inc. (CZO.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Ceapro Inc. (CZO.V)'s next earnings date?

Ceapro Inc. (CZO.V) is scheduled to release its next quarterly earnings announcement on Thursday, April 15th 2021.
View our earnings forecast for Ceapro Inc. (CZO.V)
.

Who are some of Ceapro Inc. (CZO.V)'s key competitors?

What other stocks do shareholders of Ceapro Inc. (CZO.V) own?

Who are Ceapro Inc. (CZO.V)'s key executives?

Ceapro Inc. (CZO.V)'s management team includes the following people:
  • Mr. Gilles R. Gagnon M.B.A., M.Sc., MBA, ICD.D, CEO, Pres & Director (Age 67, Pay $480k)
  • Ms. Stacy Prefontaine CPA, CA, CFO & Corp. Sec.
  • Dr. Bernhard Seifried, Director of Engineering Research & Technologies

What is Ceapro Inc. (CZO.V)'s stock symbol?

Ceapro Inc. (CZO.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CZO."

How do I buy shares of Ceapro Inc. (CZO.V)?

Shares of CZO and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Ceapro Inc. (CZO.V)'s stock price today?

One share of CZO stock can currently be purchased for approximately C$0.68.

How big of a company is Ceapro Inc. (CZO.V)?

Ceapro Inc. (CZO.V) has a market capitalization of C$52.78 million and generates C$16.14 million in revenue each year.

What is Ceapro Inc. (CZO.V)'s official website?

The official website for Ceapro Inc. (CZO.V) is www.ceapro.com.

How can I contact Ceapro Inc. (CZO.V)?

Ceapro Inc. (CZO.V)'s mailing address is 7824 51 Ave NW, EDMONTON, AB T6E 6W2, Canada. The company can be reached via phone at +1-780-4214555.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.